These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 20082934)

  • 1. Supported high-risk percutaneous coronary intervention with the Impella 2.5 device the Europella registry.
    Sjauw KD; Konorza T; Erbel R; Danna PL; Viecca M; Minden HH; Butter C; Engstrøm T; Hassager C; Machado FP; Pedrazzini G; Wagner DR; Schamberger R; Kerber S; Mathey DG; Schofer J; Engström AE; Henriques JP
    J Am Coll Cardiol; 2009 Dec; 54(25):2430-4. PubMed ID: 20082934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feasibility and long-term safety of elective Impella-assisted high-risk percutaneous coronary intervention: a pilot two-centre study.
    Burzotta F; Paloscia L; Trani C; Mascellanti M; Mongiardo R; Materazzo G; Niccoli G; Di Marco M; Leone AM; Porto I; Mazzari MA; Rebuzzi AG; Schiavoni G; Crea F
    J Cardiovasc Med (Hagerstown); 2008 Oct; 9(10):1004-10. PubMed ID: 18799962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical application of prophylactic percutaneous left ventricular assist device (TandemHeart) in high-risk percutaneous coronary intervention using an arterial preclosure technique: single-center experience.
    Rajdev S; Krishnan P; Irani A; Kim MC; Moreno PR; Sharma SK; Kini AS
    J Invasive Cardiol; 2008 Feb; 20(2):67-72. PubMed ID: 18252970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of mechanical left ventricular unloading by Impella on left ventricular dynamics in high-risk and primary percutaneous coronary intervention patients.
    Remmelink M; Sjauw KD; Henriques JP; de Winter RJ; Vis MM; Koch KT; Paulus WJ; de Mol BA; Tijssen JG; Piek JJ; Baan J
    Catheter Cardiovasc Interv; 2010 Feb; 75(2):187-94. PubMed ID: 19941329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of left ventricular unloading by Impella recover LP2.5 on coronary hemodynamics.
    Remmelink M; Sjauw KD; Henriques JP; de Winter RJ; Koch KT; van der Schaaf RJ; Vis MM; Tijssen JG; Piek JJ; Baan J
    Catheter Cardiovasc Interv; 2007 Oct; 70(4):532-7. PubMed ID: 17896398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and feasibility of elective high-risk percutaneous coronary intervention procedures with left ventricular support of the Impella Recover LP 2.5.
    Henriques JP; Remmelink M; Baan J; van der Schaaf RJ; Vis MM; Koch KT; Scholten EW; de Mol BA; Tijssen JG; Piek JJ; de Winter RJ
    Am J Cardiol; 2006 Apr; 97(7):990-2. PubMed ID: 16563902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Percutaneous left ventricular assist device: "TandemHeart" for high-risk coronary intervention.
    Aragon J; Lee MS; Kar S; Makkar RR
    Catheter Cardiovasc Interv; 2005 Jul; 65(3):346-52. PubMed ID: 15945107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Percutaneous left ventricular assist device with TandemHeart for high-risk percutaneous coronary intervention: the Mayo Clinic experience.
    Alli OO; Singh IM; Holmes DR; Pulido JN; Park SJ; Rihal CS
    Catheter Cardiovasc Interv; 2012 Nov; 80(5):728-34. PubMed ID: 22378485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous retrograde left ventricular assist support for interventions in patients with aortic stenosis and left ventricular dysfunction.
    Martinez CA; Singh V; Londoño JC; Cohen MG; Alfonso CE; O'Neill WW; Heldman AW
    Catheter Cardiovasc Interv; 2012 Dec; 80(7):1201-9. PubMed ID: 22511541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-risk percutaneous coronary intervention with the TandemHeart and Impella devices: a single-center experience.
    Schwartz BG; Ludeman DJ; Mayeda GS; Kloner RA; Economides C; Burstein S
    J Invasive Cardiol; 2011 Oct; 23(10):417-24. PubMed ID: 21972160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A first-in-man study of the Reitan catheter pump for circulatory support in patients undergoing high-risk percutaneous coronary intervention.
    Smith EJ; Reitan O; Keeble T; Dixon K; Rothman MT
    Catheter Cardiovasc Interv; 2009 Jun; 73(7):859-65. PubMed ID: 19455649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective feasibility trial investigating the use of the Impella 2.5 system in patients undergoing high-risk percutaneous coronary intervention (The PROTECT I Trial): initial U.S. experience.
    Dixon SR; Henriques JP; Mauri L; Sjauw K; Civitello A; Kar B; Loyalka P; Resnic FS; Teirstein P; Makkar R; Palacios IF; Collins M; Moses J; Benali K; O'Neill WW
    JACC Cardiovasc Interv; 2009 Feb; 2(2):91-6. PubMed ID: 19463408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [High-risk left main coronary stenting supported by percutaneous Impella Recover LP 2.5 assist device].
    Cohen R; Foucher R; Sfaxi A; Hakim M; Domniez T; Elhadad S
    Ann Cardiol Angeiol (Paris); 2010 Feb; 59(1):48-51. PubMed ID: 18789429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Real-world use of the Impella 2.5 circulatory support system in complex high-risk percutaneous coronary intervention: the USpella Registry.
    Maini B; Naidu SS; Mulukutla S; Kleiman N; Schreiber T; Wohns D; Dixon S; Rihal C; Dave R; O'Neill W
    Catheter Cardiovasc Interv; 2012 Nov; 80(5):717-25. PubMed ID: 22105829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-risk percutaneous coronary intervention using the intracardiac microaxial pump 'Impella recover'.
    Ramondo A; Napodano M; Tarantini G; Calzolari D; Nalli C; Cacciavillani L; Iliceto S
    J Cardiovasc Med (Hagerstown); 2006 Feb; 7(2):149-52. PubMed ID: 16645377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-risk PCI in acute coronary syndromes with Impella LP 2.5 device support.
    Iliodromitis KE; Kahlert P; Plicht B; Hoffmann AC; Eggebrecht H; Erbel R; Konorza TF
    Int J Cardiol; 2011 Nov; 153(1):59-63. PubMed ID: 20826017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assisted circulation using the TandemHeart during very high-risk PCI of the unprotected left main coronary artery in patients declined for CABG.
    Vranckx P; Schultz CJ; Valgimigli M; Eindhoven JA; Kappetein AP; Regar ES; Van Domburg R; Serruys PW
    Catheter Cardiovasc Interv; 2009 Aug; 74(2):302-10. PubMed ID: 19360865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of Impella Recover 2.5 left ventricular assist device in patients with cardiogenic shock or undergoing high-risk percutaneous coronary intervention procedures: experience of a high-volume center.
    Vecchio S; Chechi T; Giuliani G; Lilli A; Consoli L; Spaziani G; Giannotti F; Margheri M
    Minerva Cardioangiol; 2008 Aug; 56(4):391-9. PubMed ID: 18614983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prophylactic use of intra-aortic balloon pump for high-risk percutaneous coronary intervention: will the Impella LP 2.5 device show superiority in a clinical randomized study?
    Syed AI; Kakkar A; Torguson R; Li Y; Ben-Dor I; Collins SD; Lemesle G; Maluenda G; Xue Z; Scheinowitz M; Kaneshige K; Satler LF; Kent KM; Suddath WO; Pichard AD; Lindsay J; Waksman R
    Cardiovasc Revasc Med; 2010; 11(2):91-7. PubMed ID: 20347798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Real-world supported unprotected left main percutaneous coronary intervention with impella device; data from the USpella registry.
    Schreiber T; Wah Htun W; Blank N; Telila T; Mercado N; Briasoulis A; Kaki A; Kondur A; Munir A; Grines C
    Catheter Cardiovasc Interv; 2017 Oct; 90(4):576-581. PubMed ID: 28417594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.